Skip to main content

Table 1 Basic characteristics according to the time period of ovarian cancer diagnosis

From: Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

 

Total

1995–1999

2000–2004

2005–2009

2010–2014

 

(n = 22,880)

(n = 3740)

(n = 4863)

(n = 6317)

(n = 7960)

No. of cases

%

p-value

No. of cases

%

No. of cases

%

No. of cases

%

No. of cases

%

p-value

Age (years)

  

<.0001

        

<.0001

  < 40

3849

16.8

 

945

25.3

910

18.7

990

15.7

1004

12.6

 

 40–59

12,169

53.2

 

1813

48.5

2526

51.9

3378

53.5

4452

55.9

 

  > 59

6862

30.0

 

982

26.3

1427

29.3

1949

30.9

2504

31.5

 

SEER Stage

  

<.0001

        

<.0001

 Localized

3865

16.9

 

1683

26.6

2182

27.4

 

 Regional

2564

11.2

 

1053

16.7

1511

19.0

 

 Distant

6795

29.7

 

2843

45.0

3952

49.6

 

 Unspecified

9656

42.2

 

738

11.7

315

4.0

 

Primary treatment

  

<.0001

        

<.0001

 Surgery only

6007

26.3

 

1213

32.4

1252

25.7

1626

25.7

1916

24.1

 

 Chemotherapy only

1680

7.3

 

326

8.7

371

7.6

414

6.6

569

7.1

 

 Surgery + Chemotherapy

13,262

58.0

 

1745

46.7

2713

55.8

3805

60.2

4999

62.8

 

 Others

1931

8.4

 

456

12.2

527

10.8

472

7.5

476

6.0

 

Histology

  

<.0001

        

<.0001

 Serous carcinoma

10,837

47.4

 

1459

39.0

2119

43.6

3186

50.4

4073

51.2

 

 Mucinous carcinoma

4005

17.5

 

916

24.5

1027

21.1

951

15.1

1111

14.0

 

 Endometrioid carcinoma

2191

9.6

 

399

10.7

494

10.2

580

9.2

718

9.0

 

 Clear cell carcinoma

1923

8.4

 

164

4.4

327

6.7

551

8.7

881

11.1

 

 Others

3924

17.2

 

802

21.4

896

18.4

1049

16.6

1177

14.8

 
  1. SEER Surveillance, Epidemiology, and End Results